13.02.2014 • News • Merck • Pharmaceuticals • Reckitt Benckiser

Reckitt Benckiser Says Pharma Review Ongoing

Reckitt Benckiser has said the strategic review of its pharmaceuticals business is still in progress and it will update investors over the course of 2014.

In October 2013, the company said it was considering all options for the business, which could include selling it, spinning it off, or keeping it.

Regarding acquisitions, CEO Rakesh Kapoor said Reckitt would continue to be active in the consumer health space, but declined to comment specifically on reports that consumer companies have approached U.S. drug maker Merck & Co about its consumer business.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.